LEMZKYO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LEMZKYO Trademark

Serial Number: 79295544 • Registration: 6504557

LEMZKYO is a trademark filed by LABORATORIOS FARMACEUTICOS ROVI, S.A. on August 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LABORATORIOS FARMACEUTICOS ROVI, S.A.

C/ Julián Camarillo, 35

Entity Type: 85

Trademark Details

Filing Date

August 26, 2020

Registration Date

October 5, 2021

Published for Opposition

July 20, 2021

Goods & Services

Pharmaceutical products, namely, antibiotics, analgesics, anesthetics, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives; chemical products for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headache; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; oral contraceptives; vaccines, syringes, vials, cartridges or carpules and ampoules for medical purposes containing pharmaceutical products in the nature of antipsychotics; pharmaceutical implants for delivering insulin, namely, implantable subcutaneous drug delivery devices sold filled with insulin; sustained release medicine implants for delivering contraceptives, namely, implantable subcutaneous sustained release drug delivery devices sold filled with pharmaceutical preparations for contraceptive use; oncological preparations being pharmaceuticals for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of allergies, for the treatment of the skin wounds, thrombosis, coagulation diseases, infections, influenza, pain and inflammation; tranquilizers, antidepressants, anxiolytics; chemical products for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2026 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 27, 2025 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 15, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 24, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 24, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 5, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 5, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Aug 1, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 9, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 14, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2021 TROA
REFUSAL PROCESSED BY IB
Feb 21, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 3, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 3, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 16, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 15, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2020 DOCK
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Dec 11, 2020 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Dec 4, 2020 LIMG
APPLICATION FILING RECEIPT MAILED
Oct 24, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 15, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 8, 2020 REPR